Literature DB >> 25709987

Geranisetron versus gabapentin in preventing postoperative nausea and vomiting after middle ear surgery in adults: A double-blinded randomized clinical trial study.

Morteza Heidari1, Azim Honarmand1, Mohammadreza Safavi1, Mohsen Chitsazi1, Farnaz Khalighinejad1.   

Abstract

BACKGROUND: The incidence of postoperative nausea and vomiting (PONV) after middle ear surgery is high. In this study we want to compare the effects of intravenous granisetron and oral gabapentin as a premedication before surgery on the incidence and severity of PONV after middle ear surgery in adult patents.
MATERIALS AND METHODS: We enrolled 90 patients that were randomly divided into the three groups of 30 in each. Group I received granisetron 3 mg iv 2 minutes before induction of anesthesia; Group II received oral gabapentin 300 mg 1 hour before anesthesia and Group III received placebo. The incidence and severity of PONV were recorded each 15 minutes in the post-anesthesia care unit (PACU) and each 8 hours until 24 hours after discharge from the PACU. RESULT: The incidence and severity of nausea and vomiting at different time intervals in Groups I and Group II was significantly lower compared with Group III (P < 0.05). There was no significant difference in the incidence of side effects of study drug administration including respiratory depression, apnea, extra pyramidal disorders, drowsiness, dizziness, vertigo and headache in three groups.
CONCLUSION: The study was shown that using gabapentin and granisetron have equal anti-emetic effects, but significant differences were seen between these two groups compared to the control group. These submit the efficiency of these drugs in preventing PONV.

Entities:  

Keywords:  5HT3 receptors; American social anesthesia; gabapentin; geranisetrone; post operating nausea and vomiting (PONV); visual analogues scale

Year:  2015        PMID: 25709987      PMCID: PMC4333427          DOI: 10.4103/2277-9175.150388

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN: 2277-9175


INTRODUCTION

Postoperative nausea and vomiting (PONV) is the one of the most unpleasant complications.[1234] PONV is an unpleasant feeling that are more distressing for patients than pain.[356] The etiology of PONV is multi-factorial[1278] and its occurrence depends on duration of surgery, the type of drugs used during anesthesia,[49] the technique of anesthesia, age, sex, and smoking habit.[101112] PONV increases intraocular pressure, increase intracranial pressure,[13] causes wound dehiscence, prolongs duration of stay in the recovery room and hospital.[1415161718] Also, PONV is an uncommon cause of aspiration, dehydration, electrolytes disorder and even death[4] especially in children and elderly patients[19] and increase the cost of treatment.[20] To prevent PONV, different kinds of drugs can be used including promethazine, droperidol, ondansetron, dexamethasone and propofol.[126212223] Despite using different kinds of drugs, PONV is a common side effect yet.[2356] Each drug used has their own risks and benefits. For example deroperidol can make dry mouth.[1] Antagonists of 5HT3 receptors can cause prolonged QT interval in ECG or even cardiac arrest.[6] Khademi et al.[24] showed that using oral gabapentin (an anticonvulsant) before surgery significantly reduced the incidence of PONV after open cholecystectomy. Papadima and colleagues[25] reported that intravenous administration of granisetron (a selective serotonin 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists) before surgery reduced significantly the incidence of nausea after total thyroidectomy. There were no previous studies which compare the efficacy of gabapentin versus granisetron in reducing PONV. So, we design the present study to compare the effect of intravenous granisetron and oral gabapentin as a premedication before surgery on the incidence and severity of nausea and vomiting after the middle ear surgery in adult patients.

MATERIALS AND METHODS

The study is a randomized, double-blinded placebo controlled clinical trial that was done from November 2008 to November 2010 after obtaining institutional approval from Ethic Committee of our University and written informed consent from the patients. The inclusion criteria were patients with ASA I and ASA II, aged between 18 and 60 years, non-pregnant or lactating females, not be in menstruation period, without history of addiction or using anti-vomiting drugs, motion sickness, obesity (body mass index more than 30), central nervous system disorders especially cerebella problems who were candidate for middle ear surgery. If technique of anesthesia was changed or there was uncontrolled bleeding during surgery, the patients were excluded from the study. If we considered 0.8 power (type II statistical error 20%) to detect a significant difference between three groups with P = 0.05 (type I statistical error 0.05), 30 patients per group must be enrolled into our study. No premedication was given to the patients. Before induction of anesthesia, the patients were informed from using Visual Analogue Score Scale (VAS, 0 = no nausea, 10 = the most severe nausea experienced) for recording of severity of nausea by a nurse. The patients were randomized into three groups by using a computer generated randomization method. Group I received 3 mg iv in a volume of 3 ml 2 minutes before induction of anesthesia; Group II received oral gabapentin 300 mg 1 hour before induction of anesthesia; Group III received placebo. The study drugs were administered by a physician who was not involved in data recording. Data gathering was performed by a nurse who was not informed from the study group allocation. The standard monitoring included EKG, pulse oximetry and noninvasive blood pressure monitoring. Induction of anesthesia was done by injecting fentanyl 2 μg/kg, sodium thiopenta 5 mg/kg and atracurium 0.6 mg/kg for muscle relaxation. After 3 minutes mask ventilation under oxygen, laryngoscopy and endotracheal intubation was performed. Maintenance of anesthesia was done using isoflurane 1.2% in 50% N2O in oxygen and morphine for analgesia. At the end of surgery, neuromuscular blockade was reversed by neostigmine 0.04 mg/kg and atropine 0.02 mg/kg iv. Mean arterial blood pressure (MAP), heart rate (HR) and peripheral oxygen saturation (Spo2) were recorded throughout surgery each 15 minutes followed by recording at recovery room every 15 minutes and then after each 8 hours till 24-hours. After operation, the incidence of PONV, severity of PONV and the first time for occurrence of PONV were recorded. The severity of PONV was recorded by using VAS. The sedation score of patients after surgery was recorded by the following scale: Complete consciousness Open eyes with sleepy mood Closed eyes with good consciousness Not having good consciousness No consciousness. Data were presented as mean ± SD or numbers (%). Statistical analysis was performed using the SPSS 16 statistical software package (SPSS Inc., Chicago, IL, USA). Quantitative data were analyzed by using one way ANOVA with Bonferroni correction. Qualitative data were analyzed by using the Chi-square test. A P value less than 0.05 was considered statistically significant.

RESULTS

The demographic and clinical data including sex, age, BMI, duration of surgery, duration of recovery stay and duration of anesthesia was not significantly different among three groups (P > 0.05) [Table 1]. The incidence and severity of nausea was significantly lower in Group I and Group II in comparison with Group III [P < 0.05, Tables 2 and 3]. Also, the incidence of vomiting was significantly lower in Group I and Group II in comparison with Group III [P < 0.05, Table 4]. There was no significant difference between Group I with Group II with respect to the incidence of nausea and vomiting and severity of nausea (P > 0.05). The first time for occurrence of vomiting was significantly longer in Group I and Group II compared with Group III [P < 0.05, Table 5]. No significant was noted between Group I and Group II in this regard.
Table 1

Demographics and clinical data of patients in three groups

Table 2

Incidence of nausea at different time interval in three groups

Table 3

Severity of nausea at different time interval in three groups

Table 4

Incidence of vomiting at different time interval in three groups

Table 5

The first time for occurrence of vomiting in three groups

Demographics and clinical data of patients in three groups Incidence of nausea at different time interval in three groups Severity of nausea at different time interval in three groups Incidence of vomiting at different time interval in three groups The first time for occurrence of vomiting in three groups The level of sedation in different time intervals was not significantly different among three groups (P > 0.05). There was no significant difference in the incidence of side effects including respiratory depression, apnea, extra pyramidal disorders, drowsiness, dizziness, vertigo and headache among three groups [P > 0.05, Table 6].
Table 6

The incidence of adverse effects in three groups

The incidence of adverse effects in three groups The study showed that using Gabapentin and Granisetron have equal anti emetic effects, but significant differences seen between these two groups compared to the control group. These submit the efficiency of these drugs in preventing PONV [Figure 1].
Figure 1

The comparisons anti-emetic effects in three groups gabapentin, granisetron and control up to 24 hours after surgery

The comparisons anti-emetic effects in three groups gabapentin, granisetron and control up to 24 hours after surgery

DISCUSSION

Our study showed that using granisetron 3 mg iv 2 minutes before induction of anesthesia or using oral gabapentin 300 mg 1 hour before beginning of general anesthesia significantly reduced the incidence of nausea and vomiting and severity of nausea in comparison with placebo. No significant difference was noted between granisetron and gabapentin in prevention of PONV. Nausea and vomiting after surgery are the most unpleasant complications.[1234] The incidence of PONV is varies from 14% to 82%.[23572627] The etiology of PONV is not completely known but from the present data showed that stimulation of four groups of receptors are effective in prevention of PONV. These receptors are: Cholinergic (muscarinic), dopaminergic (D2), histaminergic (H1) and seretoninergic (5HT3).[7] Recently it was shown that antagonists of neurokinin receptors (NK1) were effective in treatment of PONV.[25] Papadima et al.[25] in a clinical trial study showed that granisetron 3 mg given before induction of anesthesia significantly reduced the incidence of PONV after total thyroidectomy. In another performed by Ganjare and colleagues[28] it was shown that granisetron 1 mg administered before induction of anesthesia was effective for prevention of PONV. They also showed that granisetron with 1 mg dose was safer than ondansetron 8 mg in this regards because granisetron caused less QT prolongation than ondansetron. The exact mechanism of granisetron for reducuing PONV has not been explained but it was postulated that it acts by stimulation of 5HT3 receptors which have anti-emetic effects.[28] Khademi et al.[24] showed that administration of oral gabapentin 2 hours before surgery significantly reduced the incidence of PONV after open cholecystectomy. Also, the previous studies[2930] showed that oral gabapentin had significant effect in reducing the incidence and severity of PONV after laparoscopic surgery. It has been postulated that anti-emetic effect of gabapentin is generated by reducing the activity of tachykinin neurotransmitter.[31] Our study had some limitation; we used only one dosage of gabapentin or granisetron. It was not clear that using different dosage of both drugs have similar effect in reducing PONV. Also, the efficacy of both drugs in reducing PONV was shown only in middle ear surgery. It is suggested that similar studies perform in the other surgeries which were accompanied with significant PONV. In conclusion our study showed that using oral gabapentin 300 mg 1 hour before surgery had similar and comparable effect to injection of granisetron 3 mg intravenously 2 minutes before induction of anesthesia in reducing the incidence of PONV and severity of nausea after middle ear surgery in adults without causing significant adverse effects.
  24 in total

Review 1.  Postoperative nausea and vomiting.

Authors:  M E Kreis
Journal:  Auton Neurosci       Date:  2006-08-30       Impact factor: 3.145

2.  Effects of preoperative gabapentin on postoperative nausea and vomiting after open cholecystectomy: a prospective randomized double-blind placebo-controlled study.

Authors:  Saeed Khademi; Fariborz Ghaffarpasand; Hamid Reza Heiran; Arshak Asefi
Journal:  Med Princ Pract       Date:  2009-12-09       Impact factor: 1.927

Review 3.  Postoperative nausea and vomiting--a review.

Authors:  A S Arif; A D Kaye; E Frost
Journal:  Middle East J Anaesthesiol       Date:  2001-06

4.  Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled study.

Authors:  C K Pandey; S Priye; S P Ambesh; S Singh; U Singh; P K Singh
Journal:  J Postgrad Med       Date:  2006 Apr-Jun       Impact factor: 1.476

5.  Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis.

Authors:  Ashraf S Habib; Ya-Ting Chen; Akiko Taguchi; X Henry Hu; Tong J Gan
Journal:  Curr Med Res Opin       Date:  2006-06       Impact factor: 2.580

6.  Effect of intravenous midazolam premedication on postoperative nausea and vomiting after cholecystectomy.

Authors:  Seied Morteza Heidari; Hamid Saryazdi; Mahmood Saghaei
Journal:  Acta Anaesthesiol Taiwan       Date:  2004-06

7.  Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting.

Authors:  L H J Eberhart; M Mauch; A M Morin; H Wulf; G Geldner
Journal:  Anaesthesia       Date:  2002-10       Impact factor: 6.955

8.  Preoperative intravenous midazolam: benefits beyond anxiolysis.

Authors:  Kevin P Bauer; Patrick M Dom; Antonio M Ramirez; Jennifer E O'Flaherty
Journal:  J Clin Anesth       Date:  2004-05       Impact factor: 9.452

9.  Midazolam reduces vomiting after tonsillectomy in children.

Authors:  W M Splinter; H B MacNeill; E A Menard; E J Rhine; D J Roberts; M H Gould
Journal:  Can J Anaesth       Date:  1995-03       Impact factor: 5.063

10.  Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial.

Authors:  Ashish Ganjare; Atul P Kulkarni
Journal:  Indian J Anaesth       Date:  2013-01
View more
  3 in total

1.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Authors:  Stephanie Weibel; Gerta Rücker; Leopold Hj Eberhart; Nathan L Pace; Hannah M Hartl; Olivia L Jordan; Debora Mayer; Manuel Riemer; Maximilian S Schaefer; Diana Raj; Insa Backhaus; Antonia Helf; Tobias Schlesinger; Peter Kienbaum; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2020-10-19

2.  Combination of gabapentin and ramosetron for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a prospective randomized comparative study.

Authors:  Kyung Mi Kim; Jin Huh; Soo Kyung Lee; Eun Young Park; Jung Min Lee; Hyo Ju Kim
Journal:  BMC Anesthesiol       Date:  2017-05-19       Impact factor: 2.217

3.  The comparative preemptive analgesic efficacy of addition of vitamin B complex to gabapentin versus gabapentin alone in women undergoing cesarean section under spinal anesthesia: A prospective randomized double-blind study.

Authors:  Marzieh Beigom Khezri; Nahid Nasseh; Ghodratollah Soltanian
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.